Synapse - Works

Results (22468)

Direct patient outreach in pediatric neurooncology to improve access to genomic profiling – The make-an-impact program

Meeting Abstract

Sait, S. F.; O'Donohue, T.; Hill, K.; Stockfish, E.; Giantini-Larsen, A.; Alano, T.; Bale, T.; Rosenblum, M.; Benhamida, J.; Dunkel, I.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Enhancement of blood-brain barrier penetration and tumor targeted drug delivery for DMG using a P-selectin targeted nanomedicine approach

Meeting Abstract

Li, B. K.; Vaynshteyn, J.; Tylawsky, D.; Vogt, K.; Raziuddin, R.; Ge, Y.; Heller, D. A.; Becher, O.; Raju, G. P.
Neuro-Oncology (2024)

Fulltext@MSK | Save

Minimally-invasive molecular diagnosis of diffuse leptomeningeal glioneuronal tumor (DLGNT) using cerebrospinal fluid cell-free DNA sequencing in pediatric and young adult patients

Meeting Abstract

Larsen, A. M. G.; Hill, K.; Hickman, R.; Bale, T. A.; Holle, B.; Mellinghoff, I.; Dunkel, I.; Souweidane, M.; Greenfield, J.; Sait, S. F.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing

Meeting Abstract

Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B. M.; Ucpinar, B. A.; Alano, T.; Doe-Tetteh, S.; DiNapoli, S.; Riviere-Cazaux, C.; Burns, T. C.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Prognostic utility of ctDNA detection in the monarchE trial of adjuvant abemaciclib plus endocrine therapy (ET) in HR+, HER2-, node-positive, high-risk early breast cancer (EBC)

Meeting Abstract

Loi, S.; Johnston, S. R. D.; Arteaga, C. L.; Graff, S. L.; Chandarlapaty, S.; Goetz, M. P.; Desmedt, C.; Sasano, H.; Liu, D.; Rodrik-Outmezguine, V.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)

Meeting Abstract

McKay, R. R.; Liu, L.; Pu, M.; Araneta, A.; Wang, L.; Castano, N.; Gomez, J.; Ajmera, A.; Ye, H.; Pili, R.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

HER2 and PD-L1 immunohistochemistry (IHC) expression, and HER2 genomic alterations: Associations and clinical outcomes for advanced bladder cancer

Meeting Abstract

Aggen, D. H.; Shah, N. J.; Zheng, J.; Alam, S. M.; Balar, O.; Niederhausern, A.; Regazzi, A. M.; Ratna, N.; Funt, S. A.; Teo, M. Y.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

HER2 mutation and bladder cancer (BC): Prevalence and clinical outcomes

Meeting Abstract

Shah, N. J.; Aggen, D. H.; Zheng, J.; Niederhausern, A.; Alam, S. M.; Balar, O.; Bahadur, N.; Watson, A.; Regazzi, A. M.; Ratna, N.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Defining molecular features associated with microsatellite instability and response to immune checkpoint blockade in urothelial carcinoma

Meeting Abstract

Alam, S. M.; Teo, M. Y.; Woo, J.; Sarfaty, M.; Funt, S. A.; Aggen, D. H.; Lee, C. H.; Carlo, M. I.; Gandhi, J.; Ratna, N.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

INSIGHT: A phase 3, randomized, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib with KIT exon 11 + 17/18 mutations

Meeting Abstract

Zalcberg, J. R.; Blay, J. Y.; Chi, P.; Jones, R. L.; Serrano, C.; Somaiah, N.; Reichmann, W.; Sprott, K.; Cox, P.; Sherman, M. L.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save